Solid Tumour Clinical Trials

7 recruiting

Solid Tumour Trials at a Glance

47 actively recruiting trials for solid tumour are listed on ClinicalTrialsFinder across 6 cities in 50 countries. The largest study group is Phase 1 with 24 trials, with the heaviest enrollment activity in London, Manchester, and Leicester. Lead sponsors running solid tumour studies include Cancer Research UK, AstraZeneca, and Nanjing Leads Biolabs Co.,Ltd.

Browse solid tumour trials by phase

Treatments under study

About Solid Tumour Clinical Trials

Looking for clinical trials for Solid Tumour? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Solid Tumour trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Solid Tumour clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 47 trials

Recruiting
Phase 2

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

Solid Tumours
Boehringer Ingelheim430 enrolled88 locationsNCT06581432
Recruiting
Phase 2

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

Advanced Solid Tumour
Nanjing Leads Biolabs Co.,Ltd110 enrolled6 locationsNCT07390383
Recruiting
Phase 1Phase 2

Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours

Solid Tumours
AstraZeneca180 enrolled18 locationsNCT07446855
Recruiting
Phase 1

A Study in People With Advanced Cancer (Solid Tumours) to Test Different Doses of BI 3810944 and to Find Out Whether it Helps

MelanomaSolid Tumours
Boehringer Ingelheim69 enrolled6 locationsNCT07224425
Recruiting
Phase 1

A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab

Solid Tumours
AstraZeneca40 enrolled19 locationsNCT07391670
Recruiting
Phase 3

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Endometrial CancerMalignant Solid Tumour
AstraZeneca700 enrolled307 locationsNCT07044336
Recruiting

A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test

Solid Tumours
Hoffmann-La Roche15,000 enrolled138 locationsNCT04529122
Recruiting
Phase 1Phase 2

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

Solid Tumours
Bristol-Myers Squibb315 enrolled19 locationsNCT07160725
Recruiting
Phase 1

A Phase I Open-Label, Single-Arm, Dose-Escalation Clinical and Pharmacology Study of CCI-001 as Monotherapy and in Combination With Standard Chemotherapy in Patients With Recurrent and/or Metastatic Solid Tumours

Cancer: Recurrent and/or Metastatic Solid Tumours
PharmaMatrix Holdings Ltd70 enrolled1 locationNCT04823897
Recruiting
Phase 2

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

Advanced Solid Tumour
Nanjing Leads Biolabs Co.,Ltd140 enrolled6 locationsNCT07111546
Recruiting
Not Applicable

Electronic Patient Reporting of Symptoms and Unmet Needs to Connect Patients With Advanced Cancer to Palliative Care Services

Advanced CancerMetastatic Cancer (Different Solid Tumour Types)Palliative Care, Health Services+1 more
Dartmouth-Hitchcock Medical Center90 enrolled1 locationNCT07195513
Recruiting
Phase 2

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

Advanced Solid Tumour
Nanjing Leads Biolabs Co.,Ltd110 enrolled7 locationsNCT07331155
Recruiting
Phase 1Phase 2

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

Advanced Solid Tumours
Pyxis Oncology, Inc220 enrolled15 locationsNCT06795412
Recruiting
Phase 1

First in Human Study of AZD9592 in Solid Tumors

Advanced Solid Tumours
AstraZeneca403 enrolled50 locationsNCT05647122
Recruiting

Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis

Nausea and VomitingOlanzapineSolid Tumours
Shandong Cancer Hospital and Institute2,000 enrolled1 locationNCT07403370
Recruiting
Phase 2

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

Advanced Solid Tumour
Nanjing Leads Biolabs Co.,Ltd230 enrolled24 locationsNCT06783647
Recruiting
Phase 1

A Study of EBC-129 in Advanced Solid Tumours

Advanced Solid Tumours
EDDC (Experimental Drug Development Centre), A*STAR Research Entities98 enrolled5 locationsNCT05701527
Recruiting
Phase 2

Hybrid Arc Palliative Radiation Therapy (HART): A Single Arm Phase II Trial

Palliative RadiotherapyMetastatic Cancer (Different Solid Tumour Types)
University of Vermont Medical Center103 enrolled1 locationNCT06778408
Recruiting
Phase 1

First in Human Study of SIM0610 in Solid Tumors

Advanced Solid Tumours
Jiangsu Simcere Pharmaceutical Co., Ltd.260 enrolled7 locationsNCT07348211
Recruiting
Phase 1Phase 2

A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours

Solid Tumours
Orion Corporation, Orion Pharma315 enrolled1 locationNCT06725758